{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:04:59Z","timestamp":1790888699561,"version":"4.1.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,7,3]],"date-time":"2012-07-03T00:00:00Z","timestamp":1341273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1038\/leu.2012.176","type":"journal-article","created":{"date-parts":[[2012,7,20]],"date-time":"2012-07-20T08:45:39Z","timestamp":1342773939000},"page":"41-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Impact of NOTCH1\/FBXW7 mutations on outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on the MRC UKALL 2003 trial"],"prefix":"10.1038","volume":"27","author":[{"given":"S","family":"Jenkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Goulden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A V","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D C","family":"Linch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R E","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,3]]},"reference":[{"key":"BFleu2012176_CR1","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1200\/JCO.2004.99.153","volume":"22","author":"R Herold","year":"2004","unstructured":"Herold R, von Stackelberg A, Hartmann R, Eisenreich B, Henze G . Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference. J Clin Oncol 2004; 22: 569\u2013570.","journal-title":"J Clin Oncol"},{"key":"BFleu2012176_CR2","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE . Treatment of acute lymphoblastic leukemia. New Engl J Med 2006; 354: 166\u2013178.","journal-title":"New Engl J Med"},{"key":"BFleu2012176_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.blre.2010.09.004","volume":"25","author":"M Paganin","year":"2011","unstructured":"Paganin M, Ferrando A . Molecular pathogenesis and targeted therapies for NOTCH1-induced T-cell acute lymphoblastic leukemia. Blood Rev 2011; 25: 83\u201390.","journal-title":"Blood Rev"},{"key":"BFleu2012176_CR4","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.it.2011.06.005","volume":"32","author":"U Koch","year":"2011","unstructured":"Koch U, Radtke F . Notch in T-ALL: new players in a complex disease. Trends Immunol 2011; 32: 434\u2013442.","journal-title":"Trends Immunol"},{"key":"BFleu2012176_CR5","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.semcancer.2004.04.011","volume":"14","author":"EM Hansson","year":"2004","unstructured":"Hansson EM, Lendahl U, Chapman G . Notch signaling in development and disease. Semin Cancer Biol 2004; 14: 320\u2013328.","journal-title":"Semin Cancer Biol"},{"key":"BFleu2012176_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1006\/dbio.2000.9960","volume":"228","author":"JS Mumm","year":"2000","unstructured":"Mumm JS, Kopan R . Notch signaling: from the outside in. Dev Biol 2000; 228: 151\u2013165.","journal-title":"Dev Biol"},{"key":"BFleu2012176_CR7","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269\u2013271.","journal-title":"Science"},{"key":"BFleu2012176_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/leu.2010.204","volume":"24","author":"L Zuurbier","year":"2010","unstructured":"Zuurbier L, Homminga I, Calvert V, te Winkel ML, Buijis-Gladdines JG, Kooi C et al. NOTCH1 and\/or FBXW7 mutations predict for initial good prednisone response but not for improved outcome in pediatric T-cell acute lymphoblastic leukemia patients treated on DCOG or COALL protocols. Leukemia 2010; 24: 2014\u20132022.","journal-title":"Leukemia"},{"key":"BFleu2012176_CR9","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1182\/blood-2005-12-4956","volume":"108","author":"S Breit","year":"2006","unstructured":"Breit S, Stanulla M, Flohr T, Schrappe M, Ludwig WD, Tolle G et al. Activating NOTCH1 mutations predict favorable early treatment response and long-term outcome in childhood precursor T-cell lymphoblastic leukemia. Blood 2006; 108: 1151\u20131157.","journal-title":"Blood"},{"key":"BFleu2012176_CR10","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1038\/leu.2010.205","volume":"24","author":"E Clappier","year":"2010","unstructured":"Clappier E, Collette S, Grardel N, Girard S, Suarez L, Brunie G et al. NOTCH1 and FBXW7 mutations have a favorable impact on early response to treatment, but not on outcome, in children with T-cell acute lymphoblastic leukemia (T-ALL) treated on EORTC trials 58881 and 58951. Leukemia 2010; 24: 2023\u20132031.","journal-title":"Leukemia"},{"key":"BFleu2012176_CR11","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1365-2141.2009.07607.x","volume":"145","author":"MJ Park","year":"2009","unstructured":"Park MJ, Taki T, Oda M, Watanabe T, Yumura-Yagu K, Kobayashi R et al. FBXW7 and NOTCH1 mutations in childhood T cell acute lymphoblastic leukaemia and T cell non-Hodgkin lymphoma. Br J Haematol 2009; 145: 198\u2013206.","journal-title":"Br J Haematol"},{"key":"BFleu2012176_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1471-2407-12-9","volume":"12","author":"MB Mansur","year":"2012","unstructured":"Mansur MB, Hassan R, Barbosa TC, Splendore A, Jotta PY, Yunes JA et al. Impact of complex NOTCH1 mutations on survival in paediatric T-cell leukaemia. BMC Cancer 2012; 12: 9.","journal-title":"BMC Cancer"},{"key":"BFleu2012176_CR13","doi-asserted-by":"publisher","first-page":"9265","DOI":"10.1128\/MCB.24.21.9265-9273.2004","volume":"24","author":"C Sanchez-Irizarry","year":"2004","unstructured":"Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC . Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol 2004; 24: 9265\u20139273.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012176_CR14","doi-asserted-by":"publisher","first-page":"34371","DOI":"10.1074\/jbc.M101343200","volume":"276","author":"N Gupta-Rossi","year":"2001","unstructured":"Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E et al. Functional interaction between SEL-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 2001; 276: 34371\u201334378.","journal-title":"J Biol Chem"},{"key":"BFleu2012176_CR15","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1182\/blood-2007-12-130096","volume":"112","author":"ML Sulis","year":"2008","unstructured":"Sulis ML, Williams O, Palomero T, Tosello V, Pallikuppam S, Real PJ et al. NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL. Blood 2008; 112: 733\u2013740.","journal-title":"Blood"},{"key":"BFleu2012176_CR16","doi-asserted-by":"publisher","first-page":"4381","DOI":"10.1182\/blood-2008-08-174748","volume":"113","author":"WR Gordon","year":"2009","unstructured":"Gordon WR, Roy M, Vardar-Ulu D, Garfinkel M, Mansour MJ, Aster JC et al. Structure of the Notch1-negative regulatory region: implications for normal activation and pathogenic signaling in T-ALL. Blood 2009; 113: 4381\u20134390.","journal-title":"Blood"},{"key":"BFleu2012176_CR17","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1172\/JCI35090","volume":"118","author":"MY Chiang","year":"2008","unstructured":"Chiang MY, Xu L, Shestova O, Histen G, L\u2019Heureux S, Romany C et al. Leukemia-associated NOTCH1 alleles are weak tumor initiators but accelerate K-ras-initiated leukemia. J Clin Invest 2008; 118: 3181\u20133194.","journal-title":"J Clin Invest"},{"key":"BFleu2012176_CR18","doi-asserted-by":"publisher","first-page":"5611","DOI":"10.1158\/0008-5472.CAN-06-4381","volume":"67","author":"A Malyukova","year":"2007","unstructured":"Malyukova A, Dohda T, von der Lehr N, Akhoondi S, Corcoran M, Heyman M et al. The tumor suppressor gene hCDC4 is frequently mutated in human T-cell acute lymphoblastic leukemia with functional consequences for Notch signaling. Cancer Res 2007; 67: 5611\u20135616.","journal-title":"Cancer Res"},{"key":"BFleu2012176_CR19","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1084\/jem.20070872","volume":"204","author":"BJ Thompson","year":"2007","unstructured":"Thompson BJ, Buonamici S, Sulis ML, Palomero T, Vilimas T, Basso G et al. The SCFFBW7 ubiquitin ligase complex as a tumor suppressor in T cell leukemia. J Exp Med 2007; 204: 1825\u20131835.","journal-title":"J Exp Med"},{"key":"BFleu2012176_CR20","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1038\/leu.2010.203","volume":"24","author":"C Kox","year":"2010","unstructured":"Kox C, Zimmermann M, Stanulla M, Leible S, Schrappe M, Ludwig WD et al. The favorable effect of activating NOTCH1 receptor mutations on long-term outcome in T-ALL patients treated on the ALL-BFM 2000 protocol can be separated from FBXW7 loss of function. Leukemia 2010; 24: 2005\u20132013.","journal-title":"Leukemia"},{"key":"BFleu2012176_CR21","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1084\/jem.20070876","volume":"204","author":"J O\u2019Neil","year":"2007","unstructured":"O\u2019Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gamma-secretase inhibitors. J Exp Med 2007; 204: 1813\u20131824.","journal-title":"J Exp Med"},{"key":"BFleu2012176_CR22","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1182\/blood-2011-01-327619","volume":"119","author":"KY Jen","year":"2012","unstructured":"Jen KY, Song IY, Banta KL, Wu D, Mao JH, Balmain A . Sequential mutations in Notch1, Fbxw7, and Tp53 in radiation-induced mouse thymic lymphomas. Blood 2012; 119: 805\u2013809.","journal-title":"Blood"},{"key":"BFleu2012176_CR23","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/nature05886","volume":"447","author":"RS Maser","year":"2007","unstructured":"Maser RS, Choudhury B, Campbell PJ, Feng B, Wong KK, Protopopov A et al. Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers. Nature 2007; 447: 966\u2013971.","journal-title":"Nature"},{"key":"BFleu2012176_CR24","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1155\/2010\/740140","volume":"28","author":"Y Erbilgin","year":"2010","unstructured":"Erbilgin Y, Sayitoglu M, Hatirnaz O, Dogru O, Akcay A, Tuysuz G et al. Prognostic significance of NOTCH1 and FBXW7 mutations in pediatric T-ALL. Dis Markers 2010; 28: 353\u2013360.","journal-title":"Dis Markers"},{"key":"BFleu2012176_CR25","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/j.1365-2141.2010.08132.x","volume":"149","author":"A Qureshi","year":"2010","unstructured":"Qureshi A, Mitchell C, Richards S, Vora A, Goulden N . Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe. Br J Haematol 2010; 149: 410\u2013413.","journal-title":"Br J Haematol"},{"key":"BFleu2012176_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1046\/j.1365-2141.1998.00574.x","volume":"100","author":"NJ Goulden","year":"1998","unstructured":"Goulden NJ, Knechtli CJ, Garland RJ, Langlands K, Hancock JP, Potter MN et al. Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia. Br J Haematol 1998; 100: 235\u2013244.","journal-title":"Br J Haematol"},{"key":"BFleu2012176_CR27","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1038\/leu.2010.237","volume":"24","author":"A Ferrando","year":"2010","unstructured":"Ferrando A . NOTCH mutations as prognostic markers in T-ALL. Leukemia 2010; 24: 2003\u20132004.","journal-title":"Leukemia"},{"key":"BFleu2012176_CR28","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","volume":"114","author":"M Remke","year":"2009","unstructured":"Remke M, Pfister S, Kox C, Toedt G, Becker N, Benner A et al. High-resolution genomic profiling of childhood T-ALL reveals frequent copy-number alterations affecting the TGF-beta and PI3K-AKT pathways and deletions at 6q15-16.1 as a genomic marker for unfavorable early treatment response. Blood 2009; 114: 1053\u20131062.","journal-title":"Blood"},{"key":"BFleu2012176_CR29","doi-asserted-by":"publisher","first-page":"4289","DOI":"10.1038\/onc.2011.138","volume":"30","author":"LA Rudner","year":"2011","unstructured":"Rudner LA, Brown KH, Dobrinski KP, Bradley DF, Garcia MI, Smith AC et al. Shared acquired genomic changes in zebrafish and human T-ALL. Oncogene 2011; 30: 4289\u20134296.","journal-title":"Oncogene"},{"key":"BFleu2012176_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nature10725","volume":"481","author":"J Zhang","year":"2012","unstructured":"Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D et al. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 2012; 481: 157\u2013163.","journal-title":"Nature"},{"key":"BFleu2012176_CR31","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente XS, Pinyol M, Quesada V, Conde L, Ordonez GR, Villamor N et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101\u2013105.","journal-title":"Nature"},{"key":"BFleu2012176_CR32","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","volume":"119","author":"R Kridel","year":"2012","unstructured":"Kridel R, Meissner B, Rogic S, Boyle M, Telenius A, Woolcock B et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 2012; 119: 1963\u20131971.","journal-title":"Blood"},{"key":"BFleu2012176_CR33","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","volume":"208","author":"G Fabbri","year":"2011","unstructured":"Fabbri G, Rasi S, Rossi D, Trifonov V, Khiabanian H, Ma J et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208: 1389\u20131401.","journal-title":"J Exp Med"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012176","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012176.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:34:06Z","timestamp":1648740846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,3]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["BFleu2012176"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.176","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,3]]},"assertion":[{"value":"25 June 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}